| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Cervical cancer screening in Europe: Quality assurance and organisation of programmes
|
Elfström, K. Miriam
|
|
2015
|
51 |
8 |
p. 950-968
19 p.
|
artikel
|
| 2 |
Combination chemotherapy with bevacizumab and S-1 for elderly patients with metastatic colorectal cancer (BASIC trial)
|
Yoshida, M.
|
|
2015
|
51 |
8 |
p. 935-941
7 p.
|
artikel
|
| 3 |
Do participants in adjuvant breast cancer trials reflect the breast cancer patient population?
|
Treweek, Shaun
|
|
2015
|
51 |
8 |
p. 907-914
8 p.
|
artikel
|
| 4 |
Efficacy-effectiveness gap as an obstacle to translating clinical trials to clinical practice
|
Srikanthan, Amirrtha
|
|
2015
|
51 |
8 |
p. 905-906
2 p.
|
artikel
|
| 5 |
Microsatellite instability, disease-free survival and role of tumour infiltrating lymphocytes (Invited editorial on ‘Predictors of disease-free survival in colorectal cancer with microsatellite instability: An AGEO multicenter study’)
|
Lynch, Henry T.
|
|
2015
|
51 |
8 |
p. 922-924
3 p.
|
artikel
|
| 6 |
Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG)
|
Green, Daniel M.
|
|
2015
|
51 |
8 |
p. 993-994
2 p.
|
artikel
|
| 7 |
Phenotypic and genotypic characterisation of biallelic mismatch repair deficiency (BMMR-D) syndrome
|
Durno, Carol A.
|
|
2015
|
51 |
8 |
p. 977-983
7 p.
|
artikel
|
| 8 |
Population based study on sentinel node biopsy before or after neoadjuvant chemotherapy in clinically node negative breast cancer patients: Identification rate and influence on axillary treatment
|
van der Heiden-van der Loo, M.
|
|
2015
|
51 |
8 |
p. 915-921
7 p.
|
artikel
|
| 9 |
Predictors of disease-free survival in colorectal cancer with microsatellite instability: An AGEO multicentre study
|
Tougeron, D.
|
|
2015
|
51 |
8 |
p. 925-934
10 p.
|
artikel
|
| 10 |
Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation
|
Huang, Dong-Sheng
|
|
2015
|
51 |
8 |
p. 969-976
8 p.
|
artikel
|
| 11 |
Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trial
|
Argilés, Guillem
|
|
2015
|
51 |
8 |
p. 942-949
8 p.
|
artikel
|
| 12 |
Response to letter commenting on “Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG)”
|
van den Heuvel-Eibrink, M.M.
|
|
2015
|
51 |
8 |
p. 995-996
2 p.
|
artikel
|
| 13 |
The power of phase II end-points for different possible mechanisms of action of an experimental treatment
|
Wason, J.M.S.
|
|
2015
|
51 |
8 |
p. 984-992
9 p.
|
artikel
|
Tijdschrift beschrijving